ADVATE

1000IU INJ PSO LQF 1+1X2ML I

Announcement of launch, break or close-out of marketing of a medicinal product
Type of announcement Effective date Alternate medicines ? Reason for interruption/cessation of marketing Estimated renewal date
Resumption of marketing 09.04.2020
Interruption of marketing 30.03.2020 0168927
Lék v jiné síle (nutná úprava dávkování), Lék je teoreticky možné nahradit i jiným koagulačním faktorem VIII (dle uvážení lékaře)
Manufacturing reasons 15.04.2020
Resumption of marketing 30.05.2018
Interruption of marketing 24.05.2018 Lék není nahraditelný
Placing on the market 01.08.2013

All reports are available in the Overview.

Back to list